Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma
Clinical trial NCT03811457 · COMPLETED
Trial details
- NCT number
- NCT03811457
- Sponsor
- UWELL Biopharma
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2018-12-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.